Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Nuclear Medicine

  Free Subscription


29.01.2024

3 Ann Nucl Med
23 Clin Nucl Med
106 J Nucl Cardiol
2 J Nucl Med
4 Nucl Med Commun
2 Nuklearmedizin
5 Phys Med Biol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Nucl Med

  1. SINGH SB, Bhandari S, Bhandari S, Bhandari S, et al
    Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review.
    Ann Nucl Med. 2024 Jan 26. doi: 10.1007/s12149-023-01896.
    PubMed         Abstract available

  2. HOTTA M, Sonni I, Thin P, Nguyen K, et al
    Visual and whole-body quantitative analyses of (68) Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with (177)Lu-DOTATATE.
    Ann Nucl Med. 2024 Jan 22. doi: 10.1007/s12149-023-01899.
    PubMed         Abstract available

  3. DERAKHSHAN S, Ghaderi B, Roshani D
    Left ventricular mechanical dyssynchrony after chemotherapy in breast cancer patients with normal rest gated SPECT-MPI.
    Ann Nucl Med. 2024 Jan 20. doi: 10.1007/s12149-023-01897.
    PubMed         Abstract available


    Clin Nucl Med

  4. ZHAO M, Zhang A, Zu M, Ma Y, et al
    Comparison of 18 F-FDG and 18 F-FAPI PET/CT Findings of Signet-Ring Cell Carcinoma of the Stomach.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005024.
    PubMed         Abstract available

  5. JAIN TK, Vohra M, Sharma BS, Dhal S, et al
    PSMA Avidity in the Heterotropic Ossification-An Incidental Finding on PSMA PET/CT.
    Clin Nucl Med. 2024 Jan 24. doi: 10.1097/RLU.0000000000005054.
    PubMed         Abstract available

  6. HU W, Qin C, Shao F, Li M, et al
    Congenital Mesoblastic Nephroma Mimic Wilms Tumor on 18 F-FDG PET/CT and PET/MR.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005063.
    PubMed         Abstract available

  7. SICILIA POZO MLN, Garcia Zoghby L, Lopez de la Osa Garcia A, Sotillo Sanchez R, et al
    The Potential Utility of 18F-FDG PET/CT in Monitoring Corticosteroid Therapy in Inflammatory Pseudotumor.
    Clin Nucl Med. 2024 Jan 16. doi: 10.1097/RLU.0000000000005038.
    PubMed         Abstract available

  8. ERGUL N, Cermik TF, Alcin G, Arslan E, et al
    Contribution of 68 Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging : Complementary Role in PSMA-Negative Cases.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005064.
    PubMed         Abstract available

  9. PARK JH, Kim HG, Kim JS, Kim SC, et al
    SPECT/CT for Early Detection of Stress Reactions After Reverse Shoulder Arthroplasty: Potential Clinical Significance.
    Clin Nucl Med. 2024 Jan 16. doi: 10.1097/RLU.0000000000005019.
    PubMed         Abstract available

  10. CHEN J, Bui P, Bui C, Mansberg R, et al
    Incidental Prostate-Specific Membrane Antigen-Avid Vestibular Schwannoma Detected on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005028.
    PubMed         Abstract available

  11. SHI X, Lan W, Bin J
    FAPI PET Missed Widespread Bone Marrow Metastases From Follicular Thyroid Cancer That Were Detected by FDG PET.
    Clin Nucl Med. 2024 Jan 24. doi: 10.1097/RLU.0000000000005031.
    PubMed         Abstract available

  12. DRAZYK A, Loh H, Bui C, Ding P, et al
    False-Positive Metastatic Bone Disease on FDG PET/CT Due to Multilevel Tophaceous Gout of the Spine.
    Clin Nucl Med. 2024 Jan 16. doi: 10.1097/RLU.0000000000005044.
    PubMed         Abstract available

  13. OU L, Zhou Y, Deng H, Chen X, et al
    18F-FDG PET/CT Findings of Ovarian Myxoid Chondrosarcoma.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005027.
    PubMed         Abstract available

  14. DING H, Wang Y, Liang J, Liu Y, et al
    Significantly Higher 68Ga-FAPI Than 18F-FDG Uptake by Hidradenocarcinoma of Head and Neck on PET/CT.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005060.
    PubMed         Abstract available

  15. SHI Q, Cheng J, Zhang Y, Su M, et al
    Intracranial Phosphaturic Mesenchymal Tumor Detected by 68 Ga-DOTATATE PET/CT.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005066.
    PubMed         Abstract available

  16. DAUNGSUPAWONG H, Wiwanitkit V
    18 F-FDG PET/CT Findings, Monkeypox, and HIV Patient.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005069.
    PubMed        

  17. FAYAND A, Kerrou K, Wendum D, Grateau G, et al
    Malignant Peritoneal Mesothelioma Complicating Familial Mediterranean Fever on 18F-FDG PET/CT.
    Clin Nucl Med. 2024 Jan 24. doi: 10.1097/RLU.0000000000005041.
    PubMed         Abstract available

  18. AL-IBRAHEEM A, Istatieh F, Abdlkadir AS, Shahait M, et al
    Cerebral and Muscular Metastases From Prostate Adenocarcinoma Initially Depicted by 177Lu-PSMA SPECT/CT.
    Clin Nucl Med. 2024 Jan 24. doi: 10.1097/RLU.0000000000005050.
    PubMed         Abstract available

  19. DONG Y, Zhao T, Ma L, Dong A, et al
    18 F-FAPI-04 PET/CT in a Case of Primary Gastric Plasmacytoma.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005065.
    PubMed         Abstract available

  20. ZHU HY, Cheng Y, Wang SY, Shao D, et al
    Urinary Endometriosis Misdiagnosed as Ureteral Malignant Tumor by PET/CT: A Case Study.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005045.
    PubMed         Abstract available

  21. WANG S, Cheng Z, Cui Y, Li X, et al
    18F-FAPI-42 PET/CT Findings in a Patient With Left Ventricular Mural Thrombus.
    Clin Nucl Med. 2024 Jan 24. doi: 10.1097/RLU.0000000000005051.
    PubMed         Abstract available

  22. LU J, Ge J, Yu H, Zhao G, et al
    Colocalization of Increased Midbrain Signals in Neuroinflammation and Tau PET Imaging Suggests the Diagnosis of Progressive Supranuclear Palsy.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005062.
    PubMed         Abstract available

  23. LEIKE T, Svantesson T, Minervini F, Bhure U, et al
    Pulmonary Amyloidoma Imitating Lung Cancer on 18F-FDG PET/CT.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005030.
    PubMed         Abstract available

  24. CUI Y, Liu Y, Du B, Li Y, et al
    Gallbladder's Adenocarcinoma With Enteroblastic Differentiation Revealed by 18F-FDG PET/CT.
    Clin Nucl Med. 2024 Jan 16. doi: 10.1097/RLU.0000000000005055.
    PubMed         Abstract available

  25. DUDEK A, Riaz S, Priftakis D, Bomanji J, et al
    Pattern of Bone Marrow Hypometabolism on 18F-FDG PET CT in Systemic Lupus Erythematous-Associated Aplastic Anemia.
    Clin Nucl Med. 2024 Jan 25. doi: 10.1097/RLU.0000000000005033.
    PubMed         Abstract available

  26. KASHIWAGI N, Nakaya Y, Yoshino Y, Tatsumi M, et al
    Calyceal Diverticulum Found Incidentally on 18F-FDG PET/CT Imaging.
    Clin Nucl Med. 2024 Jan 23. doi: 10.1097/RLU.0000000000005056.
    PubMed         Abstract available


    J Nucl Cardiol

  27. FUJIOKA K, Norikane T, Takami Y, Yamamoto Y, et al
    Feasibility of PiB PET/CT for treatment monitoring with Tafamidis in a patient with ATTR-CA.
    J Nucl Cardiol. 2024 Jan 19:101816. doi: 10.1016/j.nuclcard.2024.101816.
    PubMed        

  28. DIETZ M, Bochaton T, Al Mansour L, Tordo J, et al
    Identification of lipomatous metaplasia on CT images helps confirm prior silent myocardial infarction associated with equivocal perfusion abnormality on SPECT/CT imaging.
    J Nucl Cardiol. 2024 Jan 19:101812. doi: 10.1016/j.nuclcard.2024.101812.
    PubMed        

  29. GAEMPERLI O
    Ejection fraction and ventricular volumes on Rb PET: Validation against cardiovascular MRI.
    J Nucl Cardiol. 2024 Jan 4:101795. doi: 10.1016/j.nuclcard.2024.101795.
    PubMed        

  30. MIYATAKE M, Norikane T, Imajo M, Takami Y, et al
    LV functional evaluation on (11)C-PiB PET/CT in cardiac amyloidosis.
    J Nucl Cardiol. 2023;30:1693-1696.
    PubMed        

  31. DORAN JA, Sajjad W, Schneider MD, Gupta R, et al
    Retraction Note: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
    J Nucl Cardiol. 2023;30:2254.
    PubMed        

  32. NIELSEN MO, Schledermann H, Jensen LT
    Primary breast cancer diagnosed by 82-Rubidium myocardial perfusion PET-scan.
    J Nucl Cardiol. 2023;30:2252-2253.
    PubMed        

  33. DAKIK HA, Ghazzal Z, Haidar M
    Screening asymptomatic patients post PCI with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2248-2251.
    PubMed        

  34. CHEN LQ, Nichols KJ, Van Tosh A
    Exercise ECG must be considered in conjunction with conventional SPECT.
    J Nucl Cardiol. 2023;30:2245-2247.
    PubMed        

  35. SUTHERLAND N, Sivaratnam D, Pearson M, Better N, et al
    Use of SPECT imaging to confirm ATTR cardiac amyloid in a Tc99m pyrophosphate study artefactually compromised by a recent V/Q scan.
    J Nucl Cardiol. 2023;30:2242-2244.
    PubMed        

  36. AIKAWA T, Manabe O, Ibe T, Oyama-Manabe N, et al
    Serial assessment of cardiac involvement in sarcoidosis by delayed (18)F-fluorodeoxyglucose PET/CT.
    J Nucl Cardiol. 2023;30:2225-2228.
    PubMed        

  37. ZMAILI M, Jaber W
    First experience of LVEF assessment with cardiac amyloid SPECT scan.
    J Nucl Cardiol. 2023;30:2222-2224.
    PubMed        

  38. TAKAHASHI K, Morioka H, Sasaki D, Yamamura N, et al
    Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
    J Nucl Cardiol. 2023;30:2215-2221.
    PubMed        

  39. JALEEL J, Patel C, Khangembam B, Kumar S, et al
    Utility of 68Ga-DOTANOC PET/CT in therapeutic monitoring of cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:2213-2214.
    PubMed         Abstract available

  40. TAKAHASHI K, Sasaki D, Uemura S, Okura T, et al
    (99m)Tc-PYP SPECT/CT as part of the diagnostic workup of left ventricular apical aneurysm in a patient with hypertrophic cardiomyopathy.
    J Nucl Cardiol. 2023;30:2198-2203.
    PubMed        

  41. QAMAR I, Grewal S, Fahed AC, Weiner R, et al
    PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
    J Nucl Cardiol. 2023;30:2187-2190.
    PubMed        

  42. DILSIZIAN V, Bacharach SL, Beanlands RS, Bergmann SR, et al
    Correction to: ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.
    J Nucl Cardiol. 2023;30:2186.
    PubMed        

  43. HORGAN S, Sanghani R, Miller S, Al-Mallah M, et al
    ASNC model coverage policy: 2023 cardiac positron emission tomography.
    J Nucl Cardiol. 2023;30:2114-2185.
    PubMed        

  44. VALZANIA C, Paccagnella A, Spadotto A, Ruotolo I, et al
    Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.
    J Nucl Cardiol. 2023;30:2104-2111.
    PubMed         Abstract available

  45. BUCY L, Erpelding ML, Boursier C, Lefevre B, et al
    Real world experience of therapeutic monitoring of medically treated prosthetic valve infective endocarditis by (18)F-FDG-PET/CT.
    J Nucl Cardiol. 2023;30:2096-2103.
    PubMed         Abstract available

  46. MAIR BA, Zelt JGE, Nekesa K, Saint-Georges Z, et al
    Pharmacological and metabolic parameters of [(18)F]flubrobenguane in clinical imaging populations.
    J Nucl Cardiol. 2023;30:2089-2095.
    PubMed         Abstract available

  47. BENTSEN S, Jensen JK, Christensen E, Petersen LR, et al
    [(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure.
    J Nucl Cardiol. 2023;30:2073-2084.
    PubMed         Abstract available

  48. BULLOCK-PALMER RP
    Utility of myocardial blood flow assessment with dynamic CZT single photon emission computed tomography in patients with myocardial bridging: Is this 'wishful thinking' in this dynamic situation?
    J Nucl Cardiol. 2023;30:2068-2072.
    PubMed        

  49. XU R, Yang H, Zhang J, Chen S, et al
    Dynamic perfusion SPECT for functional evaluation in symptomatic patients with myocardial bridging.
    J Nucl Cardiol. 2023;30:2058-2067.
    PubMed         Abstract available

  50. PETRETTA M, Panico M, Mainolfi CG, Cuocolo A, et al
    Including myocardial flow reserve by PET in prediction models: Ready to fly?
    J Nucl Cardiol. 2023;30:2054-2057.
    PubMed        

  51. MIURA S, Okizaki A, Kumamaru H, Manabe O, et al
    Interaction of impaired myocardial flow reserve and extent of myocardial ischemia assessed using (13)N-ammonia positron emission tomography imaging on adverse cardiovascular outcomes.
    J Nucl Cardiol. 2023;30:2043-2053.
    PubMed         Abstract available

  52. HULTEN E, Keating FK
    Diagnosis of diffuse ischemia with SPECT relative perfusion imaging: How to eat soup with a fork?
    J Nucl Cardiol. 2023;30:2039-2042.
    PubMed        

  53. KUPUSOVIC J, Kessler L, Bruns F, Bohnen JE, et al
    Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation.
    J Nucl Cardiol. 2023;30:2018-2028.
    PubMed         Abstract available

  54. MALLET F, Poitrasson-Riviere A, Mariano-Goulart D, Agostini D, et al
    Measuring myocardial blood flow using dynamic myocardial perfusion SPECT: artifacts and pitfalls.
    J Nucl Cardiol. 2023;30:2006-2017.
    PubMed         Abstract available

  55. DAI N, Zhang B, Gong Z, Dong Z, et al
    Quantitative flow ratio derived pullback pressure gradient and CZT-SPECT measured longitudinal flow gradient for hemodynamically significant coronary artery disease.
    J Nucl Cardiol. 2023;30:1992-2002.
    PubMed         Abstract available

  56. WANG A, Mahmood U, Tang X, Jain D, et al
    A case of disappearing amyloid on technetium pyrophosphate scan.
    J Nucl Cardiol. 2023;30:1986-1991.
    PubMed         Abstract available

  57. TANG X, Dai N, Zhang B, Cai H, et al
    Comparison of 2D-QCA, 3D-QCA and coronary angiography derived FFR in predicting myocardial ischemia assessed by CZT-SPECT MPI.
    J Nucl Cardiol. 2023;30:1973-1982.
    PubMed         Abstract available

  58. NAKAJIMA K, Shibutani T
    Are nuclear medicine images quantified in 2D and 3D equally functional?
    J Nucl Cardiol. 2023;30:1968-1972.
    PubMed        

  59. IMOTO A, Tateishi E, Murakawa K, Ohta Y, et al
    Lung-to-heart ratio analysis using virtual planar images obtained from myocardial perfusion SPECT data: A phantom and clinical studies.
    J Nucl Cardiol. 2023;30:1959-1967.
    PubMed         Abstract available

  60. FUKUSHIMA K, Endo K, Yamakuni R, Kiko T, et al
    Simultaneous assessment of left ventricular mechanical dyssynchrony using integrated (13)N-ammonia PETMR system: direct comparison of PET phase analysis and MR feature tracking.
    J Nucl Cardiol. 2023;30:1947-1958.
    PubMed         Abstract available

  61. HEDEER F, Akil S, Oddstig J, Hindorf C, et al
    Diagnostic accuracy for CZT gamma camera compared to conventional gamma camera technique with myocardial perfusion single-photon emission computed tomography: Assessment of myocardial infarction and function.
    J Nucl Cardiol. 2023;30:1935-1946.
    PubMed         Abstract available

  62. AL TAHA Z, Alibazoglu D, Sabbour H, Romany I, et al
    Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies.
    J Nucl Cardiol. 2023;30:1922-1934.
    PubMed         Abstract available

  63. QUTBI M
    Adjustment of acquisition arc in cardiac malposition during myocardial perfusion SPECT imaging: computer simulation based on deterministic modeling.
    J Nucl Cardiol. 2023;30:1910-1921.
    PubMed         Abstract available

  64. TOTTLEBEN J, Torres A, Doukky R
    Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation.
    J Nucl Cardiol. 2023;30:1897-1903.
    PubMed         Abstract available

  65. KOENDERS SS, van Dalen JA, Jager PL, Mouden M, et al
    Patient-tailored risk assessment of obstructive coronary artery disease using Rubidium-82 PET-based myocardial flow quantification with visual interpretation.
    J Nucl Cardiol. 2023;30:1890-1896.
    PubMed         Abstract available

  66. HANAOKA K, Watanabe S, Morimoto-Ishikawa D, Kaida H, et al
    Impact of respiratory gating and ECG gating on (18)F-FDG PET/CT for cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:1879-1885.
    PubMed         Abstract available

  67. CHEN X, Liu C
    Deep-learning-based methods of attenuation correction for SPECT and PET.
    J Nucl Cardiol. 2023;30:1859-1878.
    PubMed         Abstract available

  68. NAYFEH M, Ahmed AI, Al-Mallah MH
    Unveiling the hidden link: deciphering the interplay between plaque characteristics and nuclear myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1851-1855.
    PubMed        

  69. HIJAZI W, Miller RJH
    Deep learning to automate SPECT MPI myocardial reorientation.
    J Nucl Cardiol. 2023;30:1836-1837.
    PubMed        

  70. ZHU F, Wang G, Zhao C, Malhotra S, et al
    Automatic reorientation by deep learning to generate short-axis SPECT myocardial perfusion images.
    J Nucl Cardiol. 2023;30:1825-1835.
    PubMed         Abstract available

  71. GATTERER C, Wollenweber T, Pichler V, Vraka C, et al
    Detection of sympathetic denervation defects in Fabry disease by hybrid [(11)C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance.
    J Nucl Cardiol. 2023;30:1810-1821.
    PubMed         Abstract available

  72. WANG Y, Yu W, Yang X, Zhang F, et al
    Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion.
    J Nucl Cardiol. 2023;30:1797-1809.
    PubMed         Abstract available

  73. IBRAHIM J, Soman P
    The past, present, and future of attenuation correction for myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1794-1796.
    PubMed        

  74. CHOPRA S, Singh SS, Sood A, Parmar M, et al
    Comparison of positional artifacts in myocardial perfusion imaging in supine and semi-reclining position using dedicated D-SPECT cardiac camera: validation using CT based attenuation correction.
    J Nucl Cardiol. 2023;30:1782-1793.
    PubMed         Abstract available

  75. SALEH JK, Barkmeier D, Frey KA, Davenport MS, et al
    Diagnostic yield of whole-body (18)F-FDG PET/CT in patients with suspected cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:1773-1781.
    PubMed         Abstract available

  76. KUPUSOVIC J, Weber M, Bruns F, Kessler L, et al
    PET/CT-identified atrial hypermetabolism is an index of atrial inflammation in patients with atrial fibrillation.
    J Nucl Cardiol. 2023;30:1761-1772.
    PubMed         Abstract available

  77. BERMAN DS
    Making fair comparisons: The potency and necessity of combining myocardial perfusion imaging and CAC scanning.
    J Nucl Cardiol. 2023;30:1751-1755.
    PubMed        

  78. MATTHEWS B, Duddleston D, Hage FG
    Myocardial perfusion imaging in congenitally corrected transposition of the great arteries.
    J Nucl Cardiol. 2023;30:2907-2910.
    PubMed        

  79. BUTT F, Siegel A
    Acute intramural hematoma of the ascending aorta discovered on myocardial perfusion SPECT.
    J Nucl Cardiol. 2023;30:2841-2843.
    PubMed        

  80. SILLANMAKI S, Iso-Mustajarvi S
    (18)F-FDG-PET of cardiac sarcoidosis with subcutaneous nodules.
    J Nucl Cardiol. 2023;30:2839-2840.
    PubMed        

  81. DAWDY J, Polina A, Abidov A
    Ascites and liver cirrhosis diagnosed on cardiac scintigraphic imaging.
    J Nucl Cardiol. 2023;30:2837-2838.
    PubMed        

  82. SUBRAMANIAN K, Bahl A, Singh H, Singh H, et al
    Invasive cardiac aspergillosis in an immuno-competent patient: distinctive imaging features on 18F-fluorodeoxyglucose (FDG)-PET/CT and 99mTc-sestamibi SPECT myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2825-2827.
    PubMed        

  83. KAUR S, Bartley P, Gordon S, Higgins A, et al
    Left ventricular assist device infection on (18)F-flourodeoxyglucose positron emission tomography.
    J Nucl Cardiol. 2023;30:2823-2824.
    PubMed         Abstract available

  84. YAMAMOTO A, Nagao M, Inai K, Shinkawa T, et al
    Coronary microvascular dysfunction detected by (13)N-ammonia positron emission tomography in a patient with repaired aortic coarctation.
    J Nucl Cardiol. 2023;30:2819-2822.
    PubMed        

  85. SUBRAMANIAN K, Mittal BR, Singh H, Sood A, et al
    Stigmata of portal hypertension depicted on myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2813-2815.
    PubMed        

  86. SUBRAMANIAN K, Mahdi R, Singh H, Sood A, et al
    Perfusion defect with characteristic anterior wall indentation on myocardial perfusion imaging caused by a large left ventricular aneurysm.
    J Nucl Cardiol. 2023;30:2809-2812.
    PubMed        

  87. RAVAL M, Siddiq S
    Extra-cardiac uptake of 99mTc-pyrophosphate scan leading to the diagnosis of stage IV metastatic prostatic adenocarcinoma.
    J Nucl Cardiol. 2023;30:2807-2808.
    PubMed        

  88. FITCH JS, Schwartz RG
    Detection and quantification of myocardial scar and LVEF with high efficiency digital SPECT: The expanding value proposition for clinical cardiology.
    J Nucl Cardiol. 2023;30:2803-2806.
    PubMed        

  89. KRAKAUER M, Ismail A, Talleruphuus U, Henriksen AC, et al
    (82)Rb and [(15)O]H(2)O myocardial perfusion PET imaging: a prospective head to head comparison.
    J Nucl Cardiol. 2023;30:2790-2802.
    PubMed         Abstract available

  90. NAKAJIMA K, Shibutani T, Massanes F, Shimizu T, et al
    Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia.
    J Nucl Cardiol. 2023;30:2773-2789.
    PubMed         Abstract available

  91. JAHANDIDEH A, Virta J, Li XG, Liljenback H, et al
    Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
    J Nucl Cardiol. 2023;30:2760-2772.
    PubMed         Abstract available

  92. JUAREZ-OROZCO LE, Niemi M, Yeung MW, Benjamins JW, et al
    Hybridizing machine learning in survival analysis of cardiac PET/CT imaging.
    J Nucl Cardiol. 2023;30:2750-2759.
    PubMed         Abstract available

  93. CHRISTENSEN NL, Nordstrom J, Madsen S, Madsen MA, et al
    Detection and correction of patient motion in dynamic (15)O-water PET MPI.
    J Nucl Cardiol. 2023;30:2736-2749.
    PubMed         Abstract available

  94. WATANABE S, Nakajima K, Toshima F, Wakabayashi H, et al
    Transthyretin amyloid cardiomyopathy disease burden quantified using (99m)Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours.
    J Nucl Cardiol. 2023;30:2721-2735.
    PubMed         Abstract available

  95. LI L, Gao J, Chen BX, Liu X, et al
    Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
    J Nucl Cardiol. 2023;30:2712-2720.
    PubMed         Abstract available

  96. DE OLIVEIRA RS, Moll-Bernardes R, de Brito AX, Pinheiro MVT, et al
    Use of PET/CT to detect myocardial inflammation and the risk of malignant arrhythmia in chronic Chagas disease.
    J Nucl Cardiol. 2023;30:2702-2711.
    PubMed         Abstract available

  97. KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
    The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
    J Nucl Cardiol. 2023;30:2692-2701.
    PubMed         Abstract available

  98. ARNFIELD EG, Tam L, Pattison DA, Younger J, et al
    Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.
    J Nucl Cardiol. 2023;30:2676-2691.
    PubMed         Abstract available

  99. SAN MIGUEL L, Goldschmidt E, Brisbin AK, Redruello M, et al
    A new perspective on an old method: gated SPECT imaging for left ventricular contractile function assessment.
    J Nucl Cardiol. 2023;30:2658-2665.
    PubMed         Abstract available

  100. CAMONI L, Dondi F
    Time-efficient cardiac imaging: early post-injection stress-first protocol myocardial perfusion SPECT with a CZT camera.
    J Nucl Cardiol. 2023;30:2655-2657.
    PubMed        

  101. CASE JA, Courter SA, McGhie A, Patel KK, et al
    Accurate and efficient rapid acquisition early post-injection stress-first CZT SPECT myocardial perfusion imaging with tetrofosmin and attenuation correction.
    J Nucl Cardiol. 2023;30:2644-2654.
    PubMed         Abstract available

  102. GRAMBOW-VELILLA J, Mahida B, Benali K, Deconinck L, et al
    Prognosis and follow-up of patients with prosthetic valve endocarditis treated conservatively in relation to WBC-SPECT imaging.
    J Nucl Cardiol. 2023;30:2633-2643.
    PubMed         Abstract available

  103. ZHANG J, Xie J, Li M, Fang W, et al
    SPECT myocardial blood flow quantitation for the detection of angiographic stenoses with cardiac-dedicated CZT SPECT.
    J Nucl Cardiol. 2023;30:2618-2632.
    PubMed         Abstract available

  104. HUDSON O, Hage FG
    Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
    J Nucl Cardiol. 2023;30:2615-2617.
    PubMed        

  105. AKINCIOGLU C, Murthi M, Romsa J, Warrington J, et al
    Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
    J Nucl Cardiol. 2023;30:2607-2614.
    PubMed         Abstract available

  106. YU W, Yang L, Zhang F, Liu B, et al
    Machine learning to predict hemodynamically significant CAD based on traditional risk factors, coronary artery calcium and epicardial fat volume.
    J Nucl Cardiol. 2023;30:2593-2606.
    PubMed         Abstract available

  107. LI L, Pang Z, Wang J, Chen Y, et al
    Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA.
    J Nucl Cardiol. 2023;30:2578-2592.
    PubMed         Abstract available

  108. CLERC OF, Frey SM, Honegger U, Amrein MLF, et al
    Coronary artery calcium score and pre-test probabilities as gatekeepers to predict and rule out perfusion defects in positron emission tomography.
    J Nucl Cardiol. 2023;30:2559-2573.
    PubMed         Abstract available

  109. SAZONOVA SI, Ilyushenkova JN, Syrkina AG, Trusov AA, et al
    Potential utility of SPECT/CT with 99mTc-Tektrotyd for imaging of post-myocardial infarction inflammation.
    J Nucl Cardiol. 2023;30:2544-2555.
    PubMed         Abstract available

  110. KHOR YM, Dorbala S
    Extra-cardiac uptake on technetium-99m pyrophosphate (Tc-99m PYP) scan: not just a matter of the heart.
    J Nucl Cardiol. 2023;30:2540-2543.
    PubMed        

  111. KHERAJANI P, Farag AA, Morgan WS, Hage FG, et al
    Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:2525-2530.
    PubMed         Abstract available

  112. ADHADUK M, Paudel B, Liu K, Ashwath M, et al
    Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
    J Nucl Cardiol. 2023;30:2514-2524.
    PubMed         Abstract available

  113. LASSEN ML, Byrne C, Hartmann JP, Kjaer A, et al
    Pulmonary blood volume assessment from a standard cardiac rubidium-82 imaging protocol: impact of adenosine-induced hyperemia.
    J Nucl Cardiol. 2023;30:2504-2513.
    PubMed         Abstract available

  114. JOHN LA, Tedrow UB, Divakaran S
    Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
    J Nucl Cardiol. 2023;30:2501-2503.
    PubMed        

  115. LUCINIAN YA, Martineau P, Poenaru R, Tremblay-Gravel M, et al
    FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:2490-2500.
    PubMed         Abstract available

  116. TAVOOSI A, Khetarpal R, Wells RG, Beanlands RSB, et al
    Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET.
    J Nucl Cardiol. 2023;30:2477-2489.
    PubMed         Abstract available

  117. AHLUWALIA N, Roshankar G, Draycott L, Jimenez-Zepeda V, et al
    Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis.
    J Nucl Cardiol. 2023;30:2464-2476.
    PubMed         Abstract available

  118. CHAN SH, Huang CK, Luzhbin D, Hou PN, et al
    Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.
    J Nucl Cardiol. 2023;30:2454-2463.
    PubMed         Abstract available

  119. PRETORIUS PH, Liu J, Kalluri KS, Jiang Y, et al
    Observer studies of image quality of denoising reduced-count cardiac single photon emission computed tomography myocardial perfusion imaging by three-dimensional Gaussian post-reconstruction filtering and deep learning.
    J Nucl Cardiol. 2023;30:2427-2437.
    PubMed         Abstract available

  120. HANSEN CL
    Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for "clean blood pool" imaging.
    J Nucl Cardiol. 2023;30:2418-2426.
    PubMed         Abstract available

  121. SAG SJM, Menhart K, Hitzenbichler F, Schmid C, et al
    (18)F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center.
    J Nucl Cardiol. 2023;30:2400-2414.
    PubMed         Abstract available

  122. KITAGAWA T, Sasaki K, Fujii Y, Ikegami Y, et al
    (18)F-sodium fluoride positron emission tomography following coronary computed tomography angiography in predicting long-term coronary events: a 5-year follow-up study.
    J Nucl Cardiol. 2023;30:2365-2378.
    PubMed         Abstract available

  123. MANNARINO T, D'Antonio A, Assante R, Zampella E, et al
    Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say.
    J Nucl Cardiol. 2023;30:2349-2360.
    PubMed         Abstract available

  124. SCIAGRA R, Linguanti F
    The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2346-2348.
    PubMed         Abstract available

  125. PICCINELLI M, Cooke CD, Folks R, Garcia EV, et al
    4D display of CT LV endocardial and epicardial models morphed from PET Rb-82 perfusion studies accurately quantifies segmental myocardial thickening.
    J Nucl Cardiol. 2023;30:2314-2326.
    PubMed         Abstract available

  126. ROZANSKI A, Gransar H, Sakul S, Miller RJH, et al
    Increasing frequency of dyspnea among patients referred for cardiac stress testing.
    J Nucl Cardiol. 2023;30:2303-2313.
    PubMed         Abstract available

  127. LIMA BB, Benz DC
    Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
    J Nucl Cardiol. 2023;30:2301-2302.
    PubMed        

  128. LASSEN ML, Rasmussen T, Byrne C, Holmvang L, et al
    Myocardial creep and cardiorespiratory motion correction improves diagnostic accuracy of Rubidium-82 cardiac positron emission tomography.
    J Nucl Cardiol. 2023;30:2289-2300.
    PubMed         Abstract available

  129. BATEMAN TM
    In 2023 PET myocardial perfusion imaging is preferred to invasive coronary angiography for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023;30:2273-2278.
    PubMed        

  130. JOHNSRUD DO, Port SC
    In 2023 invasive coronary angiography is preferred to PET myocardial perfusion imaging for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023;30:2269-2272.
    PubMed        

  131. WILLIAMS MC
    Machine learning models for PET myocardial perfusion imaging.
    J Nucl Cardiol. 2024 Jan 18:101805. doi: 10.1016/j.nuclcard.2024.101805.
    PubMed        

  132. ROZANSKI A, Miller RJH, Han D, Gransar H, et al
    Comparative Predictors of Mortality among Patients Referred for Stress SPECT versus PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2024 Jan 18:101811. doi: 10.1016/j.nuclcard.2024.101811.
    PubMed         Abstract available


    J Nucl Med

  133. GU B, Yang Z, Du X, Xu X, et al
    Imaging of Tumor Stroma Using (68)Ga-FAPI PET/CT to Improve Diagnostic Accuracy of Primary Tumors in Head and Neck Cancer of Unknown Primary: A Comparative Imaging Trial.
    J Nucl Med. 2024 Jan 25:jnumed.123.266556. doi: 10.2967/jnumed.123.266556.
    PubMed         Abstract available

  134. KIRBY A, Graf D, Suchy M, Calvert ND, et al
    It's a Trap! Aldolase-Prescribed C(4) Deoxyradiofluorination Affords Intracellular Trapping and the Tracing of Fructose Metabolism by PET.
    J Nucl Med. 2024 Jan 25:jnumed.123.266905. doi: 10.2967/jnumed.123.266905.
    PubMed         Abstract available


    Nucl Med Commun

  135. WECHALEKAR K, Hutt D, Quigley AM, Whelan C, et al
    Recommendations for good clinical practice for DPD bone scintigraphy for cardiac amyloidosis.
    Nucl Med Commun. 2024 Jan 26. doi: 10.1097/MNM.0000000000001796.
    PubMed        

  136. THOMSON WH
    Using VARSKIN+v1.2 to estimate dose from direct skin contamination with radionuclides 223Ra, 212Pb and 225Ac; considerations for Nuclear Medicine staff and associated Personal Protective Equipment (PPE).
    Nucl Med Commun. 2024 Jan 19. doi: 10.1097/MNM.0000000000001808.
    PubMed         Abstract available

  137. VINJAMURI S, Pant V, Bomanji JB, Marengo M, et al
    Assessing nuclear medicine practices: a critical evaluation of QUANUM through a quality improvement perspective and its wider relevance.
    Nucl Med Commun. 2024 Jan 22. doi: 10.1097/MNM.0000000000001815.
    PubMed         Abstract available

  138. OUCHI Y, Kishino T, Miyashita T, Mori T, et al
    Predictive value of local control by 4'-[methyl-11C]-thiotymidine PET volume parameters in p16-negative oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma.
    Nucl Med Commun. 2024 Jan 22. doi: 10.1097/MNM.0000000000001821.
    PubMed         Abstract available


    Nuklearmedizin

  139. FREUDENBERG R, Kastner D, Kotzerke J, Brogsitter C, et al
    [Evaluation of risk analysis in treatment with unsealed radioactive substances in nuclear medicine].
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2237-8639.
    PubMed        

  140. MAMAN A
    Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations.
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2238-4186.
    PubMed        


    Phys Med Biol

  141. MANDEVILLE JB, Efthimiou N, Weigand-Whittier J, Hardy EE, et al
    Partial volume correction of PET image data using geometric transfer matrices based on uniform B-splines.
    Phys Med Biol. 2024 Jan 25. doi: 10.1088/1361-6560.
    PubMed         Abstract available

  142. HINZ C, Jahnke S, Metzner R, Pflugfelder D, et al
    Setup and characterisation according to NEMA NU 4 of thephenoPET scanner, a PET system dedicated for plant sciences.
    Phys Med Biol. 2024 Jan 25. doi: 10.1088/1361-6560.
    PubMed         Abstract available

  143. BAYERLEIN R, Spencer BA, Leung EK, Omidvari N, et al
    Development of a Monte Carlo-based scatter correction method for total-body PET using the uEXPLORER PET/CT scanner.
    Phys Med Biol. 2024 Jan 24. doi: 10.1088/1361-6560/ad2230.
    PubMed         Abstract available

  144. CATES JW, Choong WS, Brubaker E
    Scintillation and Cherenkov photon counting detectors with analog silicon photomultipliers for TOF-PET.
    Phys Med Biol. 2024 Jan 22. doi: 10.1088/1361-6560/ad2125.
    PubMed         Abstract available

  145. LI X, Johnson J, Strigel RM, Bancroft LCH, et al
    Attenuation correction and truncation completion for breast PET/MR imaging using deep learning.
    Phys Med Biol. 2024 Jan 22. doi: 10.1088/1361-6560/ad2126.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.